<i>Paenibacillus alvei MP1</i> as a Producer of the Proteinaceous Compound with Activity against Important Human Pathogens, Including <i>Staphylococcus aureus</i> and <i>Listeria monocytogenes</i>
An emerging need for new classes of antibiotics is, on the one hand, evident as antimicrobial resistance continues to rise. On the other hand, the awareness of the pros and cons of chemically synthesized compounds’ extensive use leads to a search for new metabolites in already known reservoirs. Prev...
| Main Authors: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | English |
| Publicado: |
MDPI AG
2020-04-01
|
| Series: | Pathogens |
| Subjects: | |
| Acceso en liña: | https://www.mdpi.com/2076-0817/9/5/319 |